Daily non-political popular news in brief.

Promising drug combination may help those with ocular melanoma that has spread

A combination of two drugs shows promise in treating a rare and therapy-resistant type of melanoma that originates in the eye and spreads to other organs, according to a new study led by Duke University Comprehensive Cancer Center researchers.

Read more »

Keywords: promising, drug, combination, ocular, melanoma, spread

« Previous | Next »

Similar news on "Promising drug combination may help those with ocular melanoma that has spread":

1. Cancer drug works by overactivating cancer gene
   11-20-2007 · EurekAlert!
   University of Michigan researchers have discovered that bortezomib, a promising cancer drug, is able to strike a blow against melanoma tumor cells by revving up the action of a cancer-promoting gene. The results suggest a novel treatment strategy: push cancer cells into overdrive, so that they self-destruct. The laboratory-based findings may lead to ways to give bortezomib with reduced side effects.
   Similar news · Read more »
   
2. Phase II study shows combination improves survival of metastatic melanoma patients
   06-03-2007 · EurekAlert!
   Two chemotherapy drugs combined with an agent that prevents the growth of blood vessels significantly delayed the spread of tumors in patients with metastatic melanoma.
   Similar news · Read more »
   
3. 3-drug combination 'extremely promising' as first-line therapy for multiple myeloma
   12-11-2007 · EurekAlert!
   A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.
   Similar news · Read more »
   
4. New drug combination shows promise for African sleeping sickness
   11-06-2007 · EurekAlert!
   A small clinical trial in Uganda, conducted within a long-established Medecins Sans Frontieres treatment program for African sleeping sickness, has found that a new combination treatment using the drugs nifurtimox and eflornithine holds promise and deserves further evaluation. Despite the low sample size, the findings were promising: no cases of treatment failure, no treatment terminations, and no HAT- or treatment-related deaths.
   Similar news · Read more »
   
5. Enhanced environment restores memory in mice with neurodegeneration
   04-29-2007 · EurekAlert!
   Mice whose brains had lost a large number of neurons due to neurodegeneration regained long-term memories and the ability to learn after their surroundings were enriched with toys and other sensory stimuli, new studies have shown. The scientists were able to achieve the same results when they treated the mice with a specific type of drug that encourages neuronal growth. The studies suggest two promising avenues for treatments for neurodegenerative diseases such as Alzheimer's disease.
   Similar news · Read more »
   
6. Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer
   11-01-2007 · EurekAlert!
   A Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer.
   Similar news · Read more »
   
7. Less invasive lymph node biopsy method could spare thousands unnecessary operations
   09-26-2007 · EurekAlert!
   Using an ultrasound-guided fine needle to biopsy lymph nodes could spare thousands of melanoma patients every year worldwide from having to undergo unnecessary and sometimes unpleasant surgery to verify whether their cancer has spread, new research indicates.
   Similar news · Read more »
   
8. Oncolytics Biotech Inc., research collaborators demonstrate reovirus/gemcitabine
   04-17-2007 · EurekAlert!
   Researchers concluded that the synergistic combination of Reolysin and gemcitabine is a promising therapeutic regimen for study in clinical trials.
   Similar news · Read more »
   
9. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
   01-31-2008 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
   Similar news · Read more »
   
10. Male contraception: One door opens, another closes
    11-07-2006 · EurekAlert!
    Researchers have announced a breakthrough on a non-hormonal compound known as Adjudin. When injected as an attachment to a modified hormone that seeks out the testes, a low dose is a safe and effective contraceptive in rats. However, another promising drug, miglustat, has failed to make the leap from mice to men.
    Similar news · Read more »